Fate Therapeutics (FATE) PT Lowered to $65 at Oppenheimer on 'Forgettable ASH'
Tweet Send to a Friend
Oppenheimer analyst Matthew Biegler lowered the price target on Fate Therapeutics (NASDAQ: FATE) to $65.00 (from $90.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
